![Mark Etherton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Etherton
Director/Board Member at
ARGENICA THERAPEUTICS LIMITED
Profile
Mark Etherton is a Non-Executive Director at Argenica Therapeutics Ltd. since 2024.
Formerly, Dr. Etherton was an Associate Medical Director at Biogen, Inc. from 2022 to 2023.
Dr. Etherton earned a doctorate from The University of Texas Southwestern Medical Center.
Mark Etherton active positions
| Companies | Position | Start |
|---|---|---|
| ARGENICA THERAPEUTICS LIMITED | Director/Board Member | 2024-09-16 |
Former positions of Mark Etherton
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2022-12-31 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Tech/Sci/R&D Officer | - |
Training of Mark Etherton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argenica Therapeutics Ltd.
 Argenica Therapeutics Ltd. BiotechnologyHealth Technology Develops novel neuro protective therapeutics to reduce brain damage | Health Technology |
- Stock Market
- Insiders
- Mark Etherton
